COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Parkinson’s Disease Therapeutics - 1st Edition - ISBN: 9780128198827, 9780128198834

Parkinson’s Disease Therapeutics

1st Edition

Emphasis on Nanotechnological Advances

Author: Magisetty Obulesu
Paperback ISBN: 9780128198827
eBook ISBN: 9780128198834
Imprint: Academic Press
Published Date: 3rd February 2020
Page Count: 146
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Parkinson’s Disease Therapeutics: Emphasis on Nanotechnological Advances presents the latest information on the second most common neurodegenerative disorder in the elderly. Despite remarkable progress in various PD therapeutics, such as microRNAs and brain drug delivery systems, a few limitations impede their success. This book sheds light on the pros and cons of recently developed novel therapeutics. Very few books have highlighted the protective efficacy of natural products, antioxidants, and biomaterial design for other diseases.

Key Features

  • Emphasizes novel therapeutics for Parkinson’s disease, including nanotechnology, natural products and antioxidants
  • Discusses the pros and cons of recently developed therapy options for Parkinson's
  • Focuses on the efficacy of nanotechnology in overcoming the blood-brain barrier and biomaterial design


Neuroscientists, biomedical researchers and graduate and medical students

Table of Contents

1. Introduction: Parkinson’s Disease Pathology and Therapeutics
2. Biomaterials: A Boon or a Bane in the Treatment of Parkinson’s Disease
3. Blood Brain Barrier
4. Natural Compounds in the Treatment of Parkinson’s Disease
5. Curcumin: A Promising Therapeutic in Parkinson’s Disease Treatment
6. Redox Nanoparticles: The Corner Stones in the Development of Parkinson’s Disease Therapeutics
7. Liposomal Maneuvers against Parkinson’s Disease
8. Nasal Delivery Nanoparticles: An Insight into Novel Parkinson’s Disease Therapeutics
9. α-Synuclein Targeted Nanoparticles
10. Pros and Cons of Parkinson’s Disease Therapeutics


No. of pages:
© Academic Press 2020
3rd February 2020
Academic Press
Paperback ISBN:
eBook ISBN:

About the Author

Magisetty Obulesu

Magisetty Obulesu

Magisetty Obulesu is a research associate in University of Tsukuba, Tsukuba, Japan. He has 20 years of research and teaching experience. He is also an editorial board of nanotechnology journals including SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science. His research areas include food science, pathology of neurodegenerative diseases such as Alzheimer’s disease, designing polymer-based biomaterials such as hydrogels, and development of metal chelators to overcome metal induced toxicity. He has researched Alzheimer’s disease and developed an aluminium-induced neurotoxicity rabbit model. Mr. Obulesu’s present research focuses on development of redox-active injectable hydrogels of polyion complex. He has written three books and edited two more; he is also the first and corresponding author for majority of his articles.

Affiliations and Expertise

University of Tsukuba, Tsukuba, Japan

Ratings and Reviews